FDA Approved: ZYNLONTA — Original Application (ADC Therapeutics America, Inc.)

View source ↗

Summary

The FDA granted original approval for ZYNLONTA (loncastuximab tesirine) from ADC Therapeutics America, Inc. for adults with relapsed or refractory diffuse large…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Zynlonta (loncastuximab tesirine)

Snippet

ORIG AP for ZYNLONTA (LONCASTUXIMAB TESIRINE)